Despite the lack of well-controlled studies to support the use of Ginkgo biloba leaf extract for prevention and treatment of memory impairment, ginkgo products continue to be heavily marketed and widely used. In 1997, sales of Ginkgo leaf extract products reached $240 million in the United States. In Germany, more than 5 million Ginkgo prescriptions are written for the treatment of dementia, cerebral decline and peripheral arterial insufficiency. A recent summary on the patterns of medication use in the ambulatory adult population in the United States reports that Ginkgo biloba leaf extract was the second most used herbal/dietary supplement. The age group with the highest Ginkgo usage was 45 to 65 year old men and women. The use of Ginkgo biloba leaf extract for memory impairment is marketed and targeted at the healthy adult that experiences forgetfulness. Currently, the claims that Ginkgo biloba has beneficial effects on learning and memory are not supported by the literature. Ginkgo biloba extract was found to stabilize or improve several measures of cognitive function and social functioning in #Alzheimer's Disease, vascular or mixed #dementia patients. #Ginkgo biloba standardized leaf extract products that have been used in clinical trials varied and not all studies tested the product quality. The use of #CCRES Ginkgo biloba leaf extract should be monitored for drug interactions, and it should not be used in patients with a history of seizures or during pregnancy and breast-feeding. Spontaneous bleeding is a serious adverse effect, therefore, Ginkgo biloba leaf extract products should not be used in patients with a high risk for bleeding. CCRES GINKGO BILOBA
I thought you'd like this Pin on Pinterest... http://pin.it/MsS1kjX